{"title":"Clinical, Hematological, Biochemical and Radiological Characteristics for Patients With Splenic Infarction: Case Series With Literature Review.","authors":"Mariko Hakoshima, Kazuya Kitakaze, Hiroki Adachi, Hisayuki Katsuyama, Hidekatsu Yanai","doi":"10.14740/jocmr4836","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Splenic infarction is a frequently missed diagnosis in acute clinical conditions and is often under-diagnosed due to the lack of high-quality evidence on pathophysiology of splenic infarction. Due to the scarcity of such evidence, no consensus guidelines regarding the diagnostic approach and management of patients with splenic infarction exist. Most of published articles on splenic infarction are case reports and there was no systematic review on splenic infarction.</p><p><strong>Methods: </strong>We conducted a retrospective analysis of all radiologically confirmed cases of splenic infarction patients with any history of admission at National Center for Global Health and Medicine Kohnodai Hospital, from 2014 to 2020. Further, to understand the pathophysiology that causes splenic infarction, we searched the literatures on splenic infarction.</p><p><strong>Results: </strong>We found 18 patients with splenic infarction. The average age was 78 years, and about half of patients had abdominal pain; however, the other half did not have abdominal pain. One-third of patients with splenic infarction died. Leukocytosis with neutrophilia, a decrease of lymphocytes, anemia, hypoalbuminemia, and liver dysfunction were observed. Fibrinogen was decreased and D-dimer was remarkably elevated. Lactate dehydrogenase (LDH) and C-reactive protein (CRP) were remarkably increased. Six patients (33.3%) had cancer, four patients (22.2%) had atrial fibrillation, and four patients (22.2%) had infection. We found 466 case reports on splenic infarction published from 1975 to 2021. Recently, the number of case reports on splenic infarction due to infection, especially, coronavirus disease 2019 (COVID-19), has been remarkably increasing. Furthermore, we found that leukocytosis, a decrease of lymphocytes, elongated activated partial thromboplastin time, decrease of fibrinogen, liver dysfunction, elevation of LDH and blood urea nitrogen can be the prognosis predicting factors for patients with splenic infarction.</p><p><strong>Conclusion: </strong>Our study elucidated clinical, hematological, biochemical and radiological characteristics for patients with splenic infarction. We newly found significant differences in blood cell counts, coagulation markers, transaminases, LDH and blood urea nitrogen between patients who died and those who survived, suggesting that these parameters can be the prognosis predicting factors for splenic infarction. Further, our systematic review on case reports about splenic infarction showed the etiology of splenic infarction and the trend of the causative diseases.</p>","PeriodicalId":15431,"journal":{"name":"Journal of Clinical Medicine Research","volume":"15 1","pages":"38-50"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/28/4d/jocmr-15-038.PMC9881492.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Medicine Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14740/jocmr4836","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Background: Splenic infarction is a frequently missed diagnosis in acute clinical conditions and is often under-diagnosed due to the lack of high-quality evidence on pathophysiology of splenic infarction. Due to the scarcity of such evidence, no consensus guidelines regarding the diagnostic approach and management of patients with splenic infarction exist. Most of published articles on splenic infarction are case reports and there was no systematic review on splenic infarction.
Methods: We conducted a retrospective analysis of all radiologically confirmed cases of splenic infarction patients with any history of admission at National Center for Global Health and Medicine Kohnodai Hospital, from 2014 to 2020. Further, to understand the pathophysiology that causes splenic infarction, we searched the literatures on splenic infarction.
Results: We found 18 patients with splenic infarction. The average age was 78 years, and about half of patients had abdominal pain; however, the other half did not have abdominal pain. One-third of patients with splenic infarction died. Leukocytosis with neutrophilia, a decrease of lymphocytes, anemia, hypoalbuminemia, and liver dysfunction were observed. Fibrinogen was decreased and D-dimer was remarkably elevated. Lactate dehydrogenase (LDH) and C-reactive protein (CRP) were remarkably increased. Six patients (33.3%) had cancer, four patients (22.2%) had atrial fibrillation, and four patients (22.2%) had infection. We found 466 case reports on splenic infarction published from 1975 to 2021. Recently, the number of case reports on splenic infarction due to infection, especially, coronavirus disease 2019 (COVID-19), has been remarkably increasing. Furthermore, we found that leukocytosis, a decrease of lymphocytes, elongated activated partial thromboplastin time, decrease of fibrinogen, liver dysfunction, elevation of LDH and blood urea nitrogen can be the prognosis predicting factors for patients with splenic infarction.
Conclusion: Our study elucidated clinical, hematological, biochemical and radiological characteristics for patients with splenic infarction. We newly found significant differences in blood cell counts, coagulation markers, transaminases, LDH and blood urea nitrogen between patients who died and those who survived, suggesting that these parameters can be the prognosis predicting factors for splenic infarction. Further, our systematic review on case reports about splenic infarction showed the etiology of splenic infarction and the trend of the causative diseases.
背景:脾梗死是急性临床条件下经常漏诊的疾病,由于缺乏高质量的脾梗死病理生理证据,常被误诊。由于此类证据的缺乏,对于脾梗死患者的诊断方法和治疗尚无一致的指导方针。已发表的关于脾梗死的文章多为病例报道,未见对脾梗死的系统综述。方法:回顾性分析2014年至2020年在Kohnodai国立全球卫生与医学中心医院(National Center for Global Health and Medicine Hospital)所有有住院史的放射学证实的脾梗死患者。为了进一步了解脾梗死的病理生理机制,我们查阅了有关脾梗死的文献。结果:本组共发现脾梗死18例。平均年龄为78岁,大约一半的患者有腹痛;然而,另一半没有腹痛。三分之一的脾梗死患者死亡。观察到白细胞增多伴中性粒细胞增多,淋巴细胞减少,贫血,低白蛋白血症和肝功能障碍。纤维蛋白原降低,d -二聚体明显升高。乳酸脱氢酶(LDH)和c反应蛋白(CRP)显著升高。癌症6例(33.3%),房颤4例(22.2%),感染4例(22.2%)。我们发现从1975年到2021年发表的466例脾梗死报告。近年来,因感染,特别是新冠肺炎(COVID-19)引起的脾梗死病例报告明显增加。此外,我们发现白细胞增多、淋巴细胞减少、活化部分凝血活酶时间延长、纤维蛋白原降低、肝功能障碍、LDH和尿素氮升高可作为脾梗死患者预后的预测因素。结论:本研究阐明了脾梗死患者的临床、血液学、生化及影像学特征。我们新发现死亡患者与存活患者的血细胞计数、凝血标志物、转氨酶、LDH和血尿素氮存在显著差异,提示这些参数可作为脾梗死预后的预测因素。此外,我们还对脾梗死的病例报告进行了系统的回顾,揭示了脾梗死的病因和病因的趋势。